Terragen Holdings Ltd (TGH) AI Stock Analysis

• Market Cap: AU$8.59M
• Dividend Yield: N/A
• Average Volume (3M): 27.47K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.35
• Revenue Growth: -24.42%
• EPS Growth: -2.30%
• Country: AU
• Employees: N/A
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): >-0.01
• Shares Outstanding: 505,017,180
• 10 Day Avg. Volume: 51,927
• 30 Day Avg. Volume: 27,470
• PEG Ratio: 0.97
• Price to Book (P/B): 1.27
• Price to Sales (P/S): 5.15
• P/FCF Ratio: -2.74
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 38 Underperform
• Price Target: AU$0.00 ▼(-100.00% Downside)

Terragen Holdings Ltd's overall stock score is primarily impacted by its poor financial performance and weak valuation. The company's declining revenues, negative profitability, and weak cash flow metrics are significant concerns. Technical analysis also indicates bearish momentum, with the stock being oversold. The lack of positive valuation metrics further contributes to the low score.

Terragen Holdings Ltd Business Overview & Revenue Model

Company Description

Terragen Holdings Ltd (TGH) is an Australian company focused on developing and commercializing biotechnological solutions for sustainable agriculture and environmental management. The company operates primarily within the agricultural sector, offering innovative products that enhance soil health, improve crop yields, and promote eco-friendly practices. TGH's core products include microbial inoculants and fertilizers designed to optimize plant growth and resilience against environmental stressors.

How the Company Makes Money

Terragen Holdings generates revenue through the sale of its agricultural products, including microbial inoculants and specialty fertilizers. The company targets farmers, agricultural producers, and distributors, providing them with solutions that enhance crop productivity while adhering to sustainable practices. Key revenue streams come from direct sales, partnerships with agricultural distributors, and possibly licensing agreements related to its proprietary technologies. Additionally, TGH may benefit from collaborations with research institutions or agricultural organizations, which can enhance product development and market reach, ultimately contributing to its earnings.

Terragen Holdings Ltd Financial Statement Overview

Summary

Terragen Holdings Ltd is facing significant financial challenges. The company is struggling with declining revenues and profitability, as reflected in its income statement. While the balance sheet shows low leverage, the negative return on equity indicates poor financial performance. Cash flow metrics are weak, with negative operating and free cash flows. The company needs to address its profitability and cash generation issues to improve its financial health.

Income Statement

Terragen Holdings Ltd has experienced declining revenues over the past year, with a negative revenue growth rate of -6.72%. The company is facing significant profitability challenges, as indicated by negative net profit margins and EBIT margins. The gross profit margin has also decreased significantly from previous years, indicating pressure on cost management. Overall, the income statement reflects a company struggling with profitability and growth.

Balance Sheet

The balance sheet of Terragen Holdings Ltd shows a relatively low debt-to-equity ratio of 0.11, indicating conservative leverage. However, the return on equity is negative, reflecting ongoing losses and inefficiencies in generating returns for shareholders. The equity ratio is stable, suggesting a solid capital structure, but the negative ROE highlights significant profitability issues.

Cash Flow

Terragen Holdings Ltd's cash flow statement reveals negative operating cash flow and free cash flow, although there is a slight improvement in free cash flow growth. The operating cash flow to net income ratio is negative, indicating that the company is not generating sufficient cash from its operations to cover its net losses. The free cash flow to net income ratio is slightly above 1, suggesting some alignment between cash flow and accounting profits, but overall cash flow performance remains weak.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.62M	1.62M	2.14M	3.28M	2.89M	3.65M
Gross Profit	792.23K	792.23K	2.06M	3.21M	2.62M	3.19M
EBITDA	-4.70M	-4.68M	-3.50M	-3.46M	-5.67M	-6.13M
Net Income	-3.72M	-3.72M	-3.01M	-3.23M	-5.41M	-6.10M
Balance Sheet
Total Assets	8.12M	8.12M	6.95M	6.35M	9.22M	14.72M
Cash, Cash Equivalents and Short-Term Investments	4.81M	4.81M	4.54M	4.17M	6.67M	11.64M
Total Debt	735.45K	735.45K	542.23K	239.37K	332.26K	357.96K
Total Liabilities	1.55M	1.55M	1.63M	1.27M	1.46M	1.70M
Stockholders Equity	6.57M	6.57M	5.32M	5.08M	7.76M	13.02M
Cash Flow
Free Cash Flow	-3.03M	-3.03M	-2.35M	-2.91M	-4.97M	-4.93M
Operating Cash Flow	-3.03M	-3.03M	-2.32M	-2.81M	-4.80M	-4.52M
Investing Cash Flow	-682.43K	-682.43K	-132.93K	-35.20K	-118.20K	-408.02K
Financing Cash Flow	3.87M	3.87M	2.82M	351.00K	-52.70K	194.92K

Terragen Holdings Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TGH, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 11.16 is Positive, neither overbought nor oversold. The STOCH value of 23.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:TGH.

Terragen Holdings Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
CDT	46 Neutral	AU$10.34M	-1.09	-390.08%	―	―	19.94%
ABX	43 Neutral	AU$32.78M	―	-25.50%	―	-100.00%	-182.93%
RLF	41 Neutral	AU$35.81M	-16.38	-41.21%	―	140.94%	88.59%
TGH	38 Underperform	AU$8.59M	-1.91	-62.66%	―	-24.42%	-2.30%
OLY	26 Underperform	AU$7.91M	-1.15	-146.25%	―	―	-1.55%

Terragen Holdings Ltd Corporate Events

Terragen Holdings Announces Virtual Annual General Meeting

Terragen Holdings Limited has announced its upcoming Annual General Meeting, which will be held virtually on November 20, 2025. The meeting will provide shareholders with the opportunity to participate and vote online, ensuring accessibility and engagement. This event is crucial for stakeholders to discuss the company’s future strategies and operational plans, potentially impacting its market positioning and shareholder interests.

Terragen Holdings Announces Auditor Change to MVAB Assurance

Terragen Holdings Limited has announced a change in its external auditor, transitioning from SW Audit to MVAB Assurance, pending shareholder approval at the upcoming Annual General Meeting. This change, effective from November 20, 2025, is part of Terragen’s ongoing efforts to ensure robust financial oversight and aligns with regulatory requirements, potentially impacting its operational transparency and stakeholder confidence.

Terragen Holdings Announces 2025 Annual General Meeting and Director Nominations

Terragen Holdings Limited announced that its 2025 Annual General Meeting will be held on November 20, 2025. The company also noted that nominations for director elections must be submitted by October 3, 2025. This announcement is significant as it outlines the company’s governance and strategic planning processes, which are crucial for stakeholders and investors. The upcoming meeting and director nominations could influence the company’s future direction and industry positioning.

Terragen Holdings Ltd Releases 2024-2025 Corporate Governance Statement

Terragen Holdings Ltd has released its corporate governance statement for the period from 1 July 2024 to 30 June 2025, detailing its compliance with the ASX Corporate Governance Council’s Fourth Edition Principles and Recommendations. The statement highlights the adoption of a formal board charter that outlines the roles and responsibilities of the board and management, emphasizing leadership, strategic objectives, and risk management. This announcement underscores Terragen’s commitment to maintaining high governance standards, which is crucial for its operational integrity and stakeholder trust.

Terragen Holdings Issues New Share Options to Employees

Terragen Holdings Limited has announced the issuance of 1,500,000 unquoted share options with an exercise price of $0.11, as part of an employee incentive scheme. This move is aimed at enhancing employee engagement and retention, potentially impacting the company’s operational dynamics and market positioning positively.

Terragen Holdings Issues New Share Options to Boost Employee Incentives

Terragen Holdings Limited announced the issuance of 1,500,000 unquoted share options with an exercise price of $0.085 as part of an employee incentive scheme. This move is expected to enhance employee engagement and align their interests with the company’s growth objectives, potentially impacting the company’s operational dynamics and market positioning.

Terragen Holdings Issues 1.5 Million Share Options

Terragen Holdings Limited announced the issuance of 1,500,000 share options at an exercise price of $0.06 as part of an employee incentive scheme. This move is aimed at enhancing employee engagement and aligning their interests with the company’s growth objectives, potentially impacting the company’s operational dynamics and market positioning positively.

Terragen Holdings Issues 1.5 Million Share Options

Terragen Holdings Limited has announced the issuance of 1,500,000 unquoted share options with an exercise price of $0.025, as part of an employee incentive scheme. This move is likely aimed at motivating employees and aligning their interests with the company’s growth objectives, potentially impacting the company’s operational dynamics and market positioning.

Terragen Holdings: Transformative Year and Strategic Growth in Sustainable Agriculture

Terragen Holdings Limited reported a transformative year in 2025, overcoming drought challenges with resilience and focusing on growth. The company launched new probiotics for ruminants, expanded its crop solutions portfolio, and progressed international regulatory submissions. A US patent granted in July 2025 bolsters its North American expansion. Terragen aims to expand its market presence in animal nutrition and crop solutions, supported by investor confidence and scientific validation, to drive financial stability and sustainable farming practices.

Terragen Holdings Reports Increased Losses Amid Revenue Decline

Terragen Holdings Limited reported a 24% decrease in revenue from ordinary operations for the year ended June 30, 2025, compared to the previous year. The company also experienced a 24% increase in net loss attributable to members, highlighting ongoing financial challenges. Despite these setbacks, the company’s financial statements received an unqualified audit opinion, indicating compliance with accounting standards. The lack of dividends and changes in control over entities suggests a focus on stabilizing operations amidst industry challenges.